PMID: 11315357Apr 24, 2001Paper

Exogenous estrogen in systemic lupus erythematosus: oral contraceptives and hormone replacement therapy

Lupus
M Petri

Abstract

The role of exogenous estrogen in the initiation and maintenance of human SLE remains very controversial. Although cohort studies suggest an increase in the incidence of SLE with both oral contraceptives and hormone replacement therapy, recent retrospective studies suggest that the risk of flare is not increased with hormone replacement therapy. However, exogenous estrogen does increase hypercoagulability, an issue in SLE patients with antiphospholipid antibodies. The prospective SELENA study will ultimately address whether exogenous estrogen increases severe flares in SLE.

References

Nov 1, 1979·Arthritis and Rheumatism·J RoubinianJ A Sadakian
Nov 1, 1979·Arthritis and Rheumatism·A D SteinbergM Duvic
Oct 1, 1992·American Journal of Reproductive Immunology : AJRI·P LangevitzA Many
Jun 1, 1992·American Journal of Obstetrics and Gynecology·R Lindsay
Aug 1, 1986·British Journal of Rheumatology·C BarrettM L Snaith
Apr 1, 1985·Annals of the Rheumatic Diseases·G R ToddK D Buchanan
Jun 1, 1971·American Journal of Obstetrics and Gynecology·T A Chapel, R E Burns
Dec 1, 1980·Arthritis and Rheumatism·M GarovichE Pisko
Sep 1, 1995·Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association·M Petri
Mar 15, 1995·Annals of Internal Medicine·J Sánchez-GuerreroG A Colditz
Apr 14, 1994·The New England Journal of Medicine·P E Belchetz
Jun 1, 1994·Obstetrics and Gynecology·D L Kampen, B B Sherwin
Jul 1, 1993·The British Journal of Dermatology·J A Yell, S M Burge
Feb 1, 1996·British Journal of Rheumatology·G Ruiz-IrastorzaN M Buchanan
Jul 4, 1996·The New England Journal of Medicine·D B PetittiH K Ziel
May 1, 1997·Arthritis and Rheumatism·J Sanchez-GuerreroG A Colditz
Aug 6, 1997·Journal of the National Cancer Institute·M C PikeT M Mack
Jul 22, 1998·Journal of the American Geriatrics Society·K YaffeS Cummings
Sep 1, 1999·Rheumatic Diseases Clinics of North America·G L Lautenbach, M Petri
Feb 5, 2000·JAMA : the Journal of the American Medical Association·C SchairerR Hoover
Feb 17, 2000·Journal of the National Cancer Institute·R K RossM C Pike
Jun 14, 2000·Mayo Clinic Proceedings·L A FitzpatrickM R Bell
Aug 24, 2000·The New England Journal of Medicine·D M HerringtonD Waters

❮ Previous
Next ❯

Citations

Mar 15, 2005·European Journal of Pharmacology·Cristina LeminiRuth Jaimez
Mar 15, 2005·European Journal of Pharmacology·Cristina LeminiRuth Jaimez
Jun 6, 2003·Best Practice & Research. Clinical Obstetrics & Gynaecology·Glenn S BuchananD Ware Branch
Jun 6, 2003·Best Practice & Research. Clinical Obstetrics & Gynaecology·Kitty W M BloemenkampJan P Vandenbroucke
Jul 2, 2003·Journal of Clinical Pathology·C C Mok, C S Lau
Jun 6, 2008·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Robert G Lahita
Mar 25, 2009·Scandinavian Journal of Rheumatology·S Ekblom-KullbergH Julkunen
Sep 6, 2005·Gynécologie, obstétrique & fertilité·S KetariL Rokbani
Feb 25, 2003·Critical Care Nursing Clinics of North America·Theresa A Beery
May 10, 2006·Clinical Chemistry and Laboratory Medicine : CCLM·Maria Grazia AndreassiSilvia Maffei
May 1, 2002·Current Opinion in Rheumatology·Robert A S Roubey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.